New study shows that silver foil could reduce the risk of infection in hospitals
2021-07-12
(Press-News.org) New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) taking place online (9-12 July) shows that covering high-touch (the most regularly touched) surfaces in hospitals with silver-impregnated foil could significantly reduce levels of contamination by clinically important bacterial pathogens.
The study by Professor Andreas Widmer and colleagues at the University Hospital Basel, Basel, Switzerland, evaluated the antimicrobial effectiveness of a polyvinyl chloride (PVC) foil containing an integrated silver-based agent containing 2% silver ions.
The hospital environment has increasingly been recognised as having critical importance when formulating infection control measures as evidence has increased of the role it plays as a source of bacterial transmission and subsequent hospital-acquired infections. Regular cleaning and disinfection have been proposed as an option for lowering infection risk, however performing this to the required standard is a time and resource-intensive process.
An alternative approach is to use auto-disinfecting surfaces which would make it difficult for pathogens to survive and would require less thorough cleaning to achieve a safe environment in patient rooms. In this study a silver-impregnated PVC foil was applied to high-touch surfaces in patient rooms where contamination levels of bacterial pathogens were anticipated to be high.
The researchers found that contamination levels on foil-covered surfaces were significantly lower than on those without the covering. Overall, mean germ numbers were reduced by more than 60 times, while the median bioburden on untreated control surfaces was more than 3 times higher than on the antimicrobial foil. The large difference between mean and median relates to the large biological variability of germ density on the different types of surfaces.
The team also discovered that clinically important bacteria - in particular Enterococci - were significantly less likely to be present on foil-covered surfaces, and the antimicrobial effects were still present 6 months later.
The authors conclude: "A foil containing an integrated silver-based agent effectively decreases the load of clinically important disease-causing bacteria over a 6-month study period."
They add: "Auto-disinfectant foils or similar antimicrobially equipped surfaces might help prevent transmission, in particular of Gram-positive pathogens from the environment. Many studies confirm rapid recolonization (reinfection) of hospital surfaces even after vigorous disinfection. Therefore, such auto-disinfectant foils could be desirable in certain healthcare areas such as transplant units or also during outbreaks such as the SARS-CoV-2 pandemic we are currently experiencing. Further research should be extended to the antiviral activity of such surfaces, as this silver-impregnated PVC foil has been found to work in experiments against another type of coronavirus: human coronavirus HCov-229E."
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2021-07-11
Obese patients with a form of advanced prostate cancer survive longer than overweight and normal weight patients, new research has found.
The study, presented today at the European Association of Urology congress, EAU21, followed more than 1500 patients over three years. Patients classed as obese - with a BMI over 30 - had a ten percent higher survival rate than thinner patients over 36 months.
Although obesity is usually associated with an increased risk of death from many cancers and some other chronic diseases, there is some evidence in a few cancers of a survival advantage for patients with high body mass index. ...
2021-07-11
Being immersed in a stunning 'virtual' Icelandic landscape can reduce the pain caused by uncomfortable medical procedures, new research has found.
The study compared patients with and without virtual reality (VR) headsets having rigid cystoscopies, where a rigid telescope is inserted through the urethra into the bladder. The research is being presented today at the European Association of Urology congress, EAU21.
Diagnosing and treating bladder cancer usually requires checking the bladder through a cystoscopy, which is perceived by patients as unpleasant and painful. Some patients avoid follow-up and as a result suffer uncontrolled and irreversible development of the disease. It is possible to have a flexible cystoscopy, which is less painful, ...
2021-07-11
A new class of drug successfully targets treatment-resistant prostate cancers and prolongs the life of patients. The treatment delivers beta radiation directly to tumour cells, is well tolerated by patients and keeps them alive for longer than standard care, found a phase 3 trial to be presented at the European Association of Urology congress, EAU21, today.
Despite progress in medicine in recent years, metastatic castration-resistant prostate cancer remains untreatable and fatal. The new treatment, known as Lu-PSMA-617, takes a new approach, targeting a molecule called PSMA, which is known to be increased on the surfaces of the tumour cells, destroying them and their surrounding microenvironment.
Professor Johann de Bono, Professor of Experimental Cancer Medicine at The ...
2021-07-11
Using an existing drug for late-stage kidney cancer at an earlier stage of the disease could reduce the risk of cancer recurring by a third, according to new research.
The findings from the Phase III trial are presented today at the European Association of Urology congress (EAU21).
There is a high risk of kidney cancer returning, following surgery to remove tumours, but there is currently no treatment to help prevent this.
The KEYNOTE study involved just under 1000 patients with kidney cancer who had undergone surgery. Half of them were given the immunotherapy drug pembrolizumab, or pembro, and the other half a placebo.
Pembro is used to treat a number of cancers, including late-stage kidney cancer, where the disease has spread to ...
2021-07-11
Researchers in Belgium report on the case of a 90-year-old woman who was simultaneously infected with two different variants of concern (VOCs) of COVID-19, in a Case Report being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) held online this year.
On March 3 2021, the woman, whose medical history was unremarkable, was admitted to the OLV Hospital in the Belgian city of Aalst after a spate of falls. She tested positive for COVID-19 on the same day. She lived alone and received nursing care at home, and had not been vaccinated against COVID-19.
Initially, there were no ...
2021-07-11
New research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, reveals raw dog food to be a major source of antibiotic-resistant bacteria, making it an international public health risk.
With some of the multidrug-resistant bacteria in raw dog food identical to those found in hospital patients in several different European countries, the researchers say the trend for feeding dogs raw food may be fuelling the spread of antibiotic resistant-bacteria.
Drug-resistant infections kill an estimated 700,000 people a year globally and, with the figure projected to rise to 10 million ...
2021-07-11
The dangerous mcr-1 gene, which provides resistance to the last-resort antibiotic colistin, has been found in four healthy humans and two pet dogs. In two cases, both dog and owner were harbouring the gene, according to new research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) held online this year.
Since first being reported in China in 2015, the mcr-1 gene has been found in various people and animals around the world. It confers resistance to colistin, an antibiotic of last resort used to treat infections from some bacteria resistant to all other antibiotics. The nightmare scenario that could emerge is mcr-1 combining with already drug-resistant bacteria ...
2021-07-10
Nashville, Tenn. (3:24 p.m. EDT--July 10, 2021)--Approximately 12 percent of patients who underwent shoulder stabilization surgery experience arthritis in the shoulder joint within a seven-year period, according to research presented today at the American Orthopedic Society for Sports Medicine-Arthroscopy Association of North America Combined 2021 Annual Meeting.
"While arthroscopic stabilization for posterior glenohumeral instability has shown excellent success preventing recurrent instability and allowing return to sport, eventual progression to glenohumeral arthritis ...
2021-07-10
Nashville, Tenn. (July 10 2021--2:25 EDT)--Patients undergoing hip arthroscopy with high-grade cartilage damage do not see as positive results compared with patients with lower grade cartilage damage, according to research reported today at the American Orthopedic Society of Sports Medicine- Arthroscopy Association of North America Combined 2021 Annual Meeting.
The research was presented by Dominic Carreira, MD, of Peachtree Orthopedics in Atlanta, Ga. Dr. Carreira and his colleagues sought to determine what the impact of acetabular cartilage damage on outcomes following primary repair of acetabular labral tears.
When articular cartilage is damaged, joint ...
2021-07-10
Nashville, Tenn. (1:35 p.m. EDT--July 10, 2021) -- Use of a biodegradable balloon spacer during massive rotator cuff tear surgery produced similar outcomes when compared to partial rotator cuff repair for patients with massive rotator cuff tears (MRCTs) at 24-month follow up, with potential for early improvement, according to research presented today at the American Orthopedic Society of Sports Medicine - Arthroscopy Association of North America Combined 2021 Annual Meeting.
Despite various treatment options, the successful management of irreparable, MRCTs remains challenging. Implantation of a biodegradable subacromial balloon spacer has gained considerable interest for the treatment of MCRTs due to its potential to recenter the humeral ...
LAST 30 PRESS RELEASES:
[Press-News.org] New study shows that silver foil could reduce the risk of infection in hospitals